中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
8期
746-748
,共3页
抗肿瘤药%静脉用药集中配置中心%合理用药
抗腫瘤藥%靜脈用藥集中配置中心%閤理用藥
항종류약%정맥용약집중배치중심%합리용약
Anti-tumor drug%Pharmacy intravenous admixture services%Rational use of drug
目的：提高抗肿瘤静脉用药的安全性和有效性，降低不良反应的发生率。方法：收集静脉用药集中配置中心（PIVAS）各工作环节相关资料和我院近5年抗肿瘤静脉用药的不合理用药医嘱、医护沟通记录等，依据《静脉用药集中调配质量管理规范》、药品说明书、相关文献及药学工具书等，从合理配置、合理使用及不良反应防治等方面进行分析与要点探讨。结果与结论：为保证抗肿瘤静脉用药的安全、有效，应从溶媒、剂量、给药方式、给药顺序、给药时间、辅助用药等方面全面监控。我院开展PIVAS集中配置后，抗肿瘤化疗药、辅助用药及中药注射剂使用行为逐步得以完善、规范。
目的：提高抗腫瘤靜脈用藥的安全性和有效性，降低不良反應的髮生率。方法：收集靜脈用藥集中配置中心（PIVAS）各工作環節相關資料和我院近5年抗腫瘤靜脈用藥的不閤理用藥醫囑、醫護溝通記錄等，依據《靜脈用藥集中調配質量管理規範》、藥品說明書、相關文獻及藥學工具書等，從閤理配置、閤理使用及不良反應防治等方麵進行分析與要點探討。結果與結論：為保證抗腫瘤靜脈用藥的安全、有效，應從溶媒、劑量、給藥方式、給藥順序、給藥時間、輔助用藥等方麵全麵鑑控。我院開展PIVAS集中配置後，抗腫瘤化療藥、輔助用藥及中藥註射劑使用行為逐步得以完善、規範。
목적：제고항종류정맥용약적안전성화유효성，강저불량반응적발생솔。방법：수집정맥용약집중배치중심（PIVAS）각공작배절상관자료화아원근5년항종류정맥용약적불합리용약의촉、의호구통기록등，의거《정맥용약집중조배질량관리규범》、약품설명서、상관문헌급약학공구서등，종합리배치、합리사용급불량반응방치등방면진행분석여요점탐토。결과여결론：위보증항종류정맥용약적안전、유효，응종용매、제량、급약방식、급약순서、급약시간、보조용약등방면전면감공。아원개전PIVAS집중배치후，항종류화료약、보조용약급중약주사제사용행위축보득이완선、규범。
OBJECTIVE:To enhance the safety and effectiveness of the anti-tumor intravenous drugs and reduce the incidence of adverse drug reactions. METHODS:The data related to each work link in pharmacy intravenous admixture services (PIVAS), the irrational medical orders of the anti-tumor intravenous drugs in recent five years and the record on communication between phy-sicians and nurses were collected for analysis with regard to rational allocation and use of anti-tumor intravenous drugs and the pre-vention and treatment of averse drug reactions induced by anti-tumor intravenous drugs in accordance with“Quality Control Practic-es on Centralized Dispensing and Allocation of Intravenous Drugs,”package inserts of drugs,the pertinent literature and pharma-cy-related reference books,etc. RESULTS & CONCLUSIONS:To ensure the medication safety of effectiveness of the anti-tumor intravenous drugs,a comprehensive monitoring on solvents,dose,mode of administration,administration order,delivery time and adjuvants is necessary. After carrying out centralized allocation in PIVAS,the use of anti-tumor chemotherapy drugs,adjuvant drugs and traditional Chinese medicine injections has been gradually improved and standardized.
